Why the study?
The study investigated the costs of delivering the Tailored Activity Program and potential cost savings from health sector and societal perspectives for people living with dementia and their caregivers.
Does the Tailored Activity Program reduce costs from health sector and societal perspectives in people living with dementia and their caregivers?
Does the Tailored Activity Program reduce costs from health sector and societal perspectives in people living with dementia and their caregivers?
The Tailored Activity Program may reduce healthcare and societal costs over 6 months for people living with dementia and their caregivers, driven by lower healthcare utilization.
TAP may be cost-neutral in dementia dyads; extends prior efficacy RCTs to include economic endpoints.
We investigated costs of delivering the Tailored Activity Program (TAP) and cost savings from two perspectives (health sector and societal) for people living with dementia (PLWD) and their caregivers (dyads) compared to attention control (AC) using data from a randomized controlled trial. The evaluation assessed intervention delivery costs and caregiver reported health care utilization. The total intervention cost of TAP was $1707/dyad versus $864/dyad for AC, and total costs over 6 months for TAP dyads as compared to AC were $1299 (CI: -$10,496, $7898) less from the healthcare perspective, and $761 (CI: -$10,133, $8611) less from the societal perspective. TAP cost savings are driven by lower use of healthcare services among participating dyads, but further analyses with larger samples is warranted to confirm its financial impact.
No takes yet. Share an insight, caveat, or question.
Pizzi et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: